AACR Project GENIE®: Participation

Participation Map

PARTICIPATING INSTITUTIONS: North America

• Children’s Hospital Los Angeles (Los Angeles, California, United States of America)
• Children’s Hospital of Philadelphia (Philadelphia, Pennsylvania, United States of America)
• Columbia University Medical Center (New York, New York, United States of America)
• Duke University Medical Center (Durham, North Carolina, United States of America)
• Dana-Farber Cancer Institute (Boston, Massachusetts, United States of America)
• The Louisiana State University Health Sciences Center (New Orleans, Louisiana, United States of America)
• Memorial Sloan Kettering Cancer Center (New York, New York, United States of America)
• Providence Cancer Institute (Portland, Oregon, United States of America)
• Sidney Kimmel Cancer Center at Johns Hopkins University; Allegheny Health Network, Affiliate (Baltimore, Maryland, United States of America)
• The University of California, San Francisco – Helen Diller Family Comprehensive Cancer Center (San Francisco, California, United States of America)
• The University of Chicago (Chicago, Illinois, United States of America)
• University Health Network – Princess Margaret Cancer Centre (Toronto, Ontario, Canada)
• University of Miami – Sylvester Comprehensive Cancer Center (Miami, Florida, United States of America)
• Vanderbilt University Medical Center / Ingram Cancer Center (Nashville, Tennessee, United States of America)
• Wake Forest University Health Sciences (Winston-Salem, North Carolina, United States of America)
• Yale University (New Haven, Connecticut, United States of America)

Participating Institutions: Europe and the United Kingdom

• Institut Gustave Roussy (Paris, France)
• The Netherlands Cancer Institute, Amsterdam, on behalf of the Center for Personalized Cancer Treatment (Utrecht, Netherlands)
• Vall d’Hebron Institute of Oncology (Barcelona, Spain)

Participating Institutions: Asia

• Korea University Anam Hospital (Seoul, Korea)

Participating Institution Requirements

• Provide 500 genomic records to start (Data must be CLIA- or ISO-certified)
• Provide 500 genomic records each subsequent year of participation (Data must be CLIA- or ISO-certified)
• Limited Data sets as defined by 45 C.F.R. § 164.514(e) will be provided
• If de-identified datasets are provided, the process must adhere to the project’s established protocols
• Maintain IRB approval
• Meet data standards and deadlines
• Participate in meetings
• Participate in committees and subcommittees
• Execute the Main Participation Agreement and agree to all exhibits, including the Data User Agreement

apply to become a participating institution

• The open call for new participating institutions will begin on May 1st, 2022. Find more information about the 2022 GENIE New Participant Open call here.
• Note: Past applications were evaluated based on the following criteria:
  AACR Project GENIE® Participation Evaluation Criteria (Previous)

Strategic Partners

• cBioPortal (New York, New York)
• Sage Bionetworks (Seattle, WA)

strategic partner requirements

• Significant prior experience in similar projects
• Secure, HIPAA-compliant infrastructure
• Established and accepted platforms
• Significant bioinformatics expertise

For a list of individual contributors, visit our Participating Individuals page.

Last Updated: April 17, 2024